cytidine has been researched along with B-Cell Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryan, JN; Flesner, BK; Kumar, SR | 1 |
| Bontemps, F; Cardoen, S; Delacauw, A; Ferrant, A; Rosier, JF; Smal, C; Van den Berghe, G; Van Den Neste, E | 1 |
2 other study(ies) available for cytidine and B-Cell Leukemia
| Article | Year |
|---|---|
6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cytidine; DNA-Cytosine Methylases; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Down-Regulation; Leukemia, B-Cell; Leukemia, T-Cell; Lymphoma; Thioguanine | 2014 |
Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Topics: Antineoplastic Agents; Cell Cycle; Cell Survival; Cladribine; Cytidine; Deoxycytidine; Deoxycytidine Kinase; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Leukemia, B-Cell; Nucleotides; Phosphorylation; Ribonucleotide Reductases; Thymidine Kinase; Tumor Cells, Cultured | 2001 |